Zobrazeno 1 - 10
of 16
pro vyhledávání: '"E W, Alton"'
Publikováno v:
European Respiratory Journal. 7:2050-2056
New treatments for cystic fibrosis (CF), including gene therapy, are currently being assessed. These aim to correct the basic defects of increased sodium absorption and decreased chloride secretion in airway epithelia. Assessment of these bioelectric
Autor:
U, Griesenbach, E W, Alton
Publikováno v:
Current opinion in molecular therapeutics. 3(4)
Cystic fibrosis (CF) is a monogenic disorder and is therefore a good candidate for gene therapy. Initial clinical trials provided proof-of-principle for gene transfer to the airways, but efficiency was low and likely to be insufficient for clinical b
Publikováno v:
Advances in experimental medicine and biology. 465
Autor:
E W, Alton, D M, Geddes
Publikováno v:
British journal of hospital medicine. 58(1)
Over the last 5 years a number of articles have been published on gene therapy for a range of diseases. The initial tone of a number of these articles evoked high expectations, particularly from the public. Over the last 2-3 years data from these stu
Autor:
D, Li, D, Wang, S, Majumdar, B, Jany, S R, Durham, J, Cottrell, N, Caplen, D M, Geddes, E W, Alton, P K, Jeffery
Publikováno v:
The Journal of pathology. 181(3)
Using digoxigenin-UTP-labelled human HAM-1 (92 bp) or SMUC41 (850 bp) cRNA probes, the expression and localization of MUC2 gene transcripts were determined by in situ hybridization in human nasal tissues obtained as biopsies from 12 patients with cys
Autor:
G, McLachlan, L P, Ho, H, Davidson-Smith, J, Samways, H, Davidson, B J, Stevenson, A D, Carothers, E W, Alton, P G, Middleton, S N, Smith, G, Kallmeyer, U, Michaelis, S, Seeber, K, Naujoks, A P, Greening, J A, Innes, J R, Dorin, D J, Porteous
Publikováno v:
Gene therapy. 3(12)
The first phase I study of cystic fibrosis gene therapy using cationic liposomes to deliver the cystic fibrosis conductance regulator gene to the nose reported partial and transient correction of the nasal transepithelial ion transport defect, While
Autor:
E W, Alton, A A, Norris
Publikováno v:
The Journal of allergy and clinical immunology. 98(5 Pt 2)
Nedocromil sodium has been shown to be capable of inhibiting chloride ion flux in mast cells, epithelial cells, and neurons. This feature may explain how it can prevent responses such as mast-cell degranulation, the effects of osmolarity changes in t
Autor:
J R, Dorin, R, Farley, S, Webb, S N, Smith, E, Farini, S J, Delaney, B J, Wainwright, E W, Alton, D J, Porteous
Publikováno v:
Gene therapy. 3(9)
Quantifying the level of transgene expression necessary for phenotypic effect is an important consideration in designing somatic gene therapy protocols. A nonlinear relationship between phenotype and gene activity is predicted by control analysis for
Autor:
A A, Norris, E W, Alton
Publikováno v:
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology. 26(3)
Publikováno v:
Gene therapy. 2(10)
Functional assessment of the efficacy of CFTR gene transfer protocols in humans has previously involved measurement of in vivo potential difference. We have studied whether freshly obtained airway epithelial cells may provide suitable tissue for stud